These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 22489661)

  • 1. Radiation/paclitaxel treatment of p53-abnormal non-small cell lung cancer xenograft tumor and associated mechanism.
    Li G; Zhao J; Peng X; Liang J; Deng X; Chen Y
    Cancer Biother Radiopharm; 2012 May; 27(4):227-33. PubMed ID: 22489661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis induced by the methanol extract of Salvia miltiorrhiza Bunge in non-small cell lung cancer through PTEN-mediated inhibition of PI3K/Akt pathway.
    Ye YT; Zhong W; Sun P; Wang D; Wang C; Hu LM; Qian JQ
    J Ethnopharmacol; 2017 Mar; 200():107-116. PubMed ID: 28088493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTEN mutations and relationship to EGFR, ERBB2, KRAS, and TP53 mutations in non-small cell lung cancers.
    Jin G; Kim MJ; Jeon HS; Choi JE; Kim DS; Lee EB; Cha SI; Yoon GS; Kim CH; Jung TH; Park JY
    Lung Cancer; 2010 Sep; 69(3):279-83. PubMed ID: 20018398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non‑coding RNA FER1L4 inhibits cell proliferation and promotes cell apoptosis via the PTEN/AKT/p53 signaling pathway in lung cancer.
    Ouyang L; Yang M; Wang X; Fan J; Liu X; Zhang Y; Shu Y
    Oncol Rep; 2021 Jan; 45(1):359-367. PubMed ID: 33416121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubiquitin specific peptidase 49 inhibits non-small cell lung cancer cell growth by suppressing PI3K/AKT signaling.
    Shen WM; Yin JN; Xu RJ; Xu DF; Zheng SY
    Kaohsiung J Med Sci; 2019 Jul; 35(7):401-407. PubMed ID: 31001918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of non-small cell lung cancer cells to the inhibitors of phosphatidylinositol 3-kinase/Akt- and MAPK kinase 4/c-Jun NH2-terminal kinase pathways: an effective therapeutic strategy for lung cancer.
    Lee HY; Oh SH; Suh YA; Baek JH; Papadimitrakopoulou V; Huang S; Hong WK
    Clin Cancer Res; 2005 Aug; 11(16):6065-74. PubMed ID: 16115952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VAOS, a novel vanadyl complexes of alginate saccharides, inducing apoptosis via activation of AKT-dependent ROS production in NSCLC.
    Zhou L; Yi Y; Yuan Q; Zhang J; Li Y; Wang P; Xu M; Xie S
    Free Radic Biol Med; 2018 Dec; 129():177-185. PubMed ID: 30223019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyoxometalate SbW9 regulates proliferation and apoptosis of NSCLC cells via PTEN-dependent AKT signaling pathway.
    Sun HB; Xu L; Wang ZX; Zheng Y; Zhao Y; Yin YY; Han XL; Xu ZN
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7959-7967. PubMed ID: 31599421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased tissue factor expression is associated with reduced survival in non-small cell lung cancer and with mutations of TP53 and PTEN.
    Regina S; Valentin JB; Lachot S; Lemarié E; Rollin J; Gruel Y
    Clin Chem; 2009 Oct; 55(10):1834-42. PubMed ID: 19661141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-invasive effects of CXCR4 and FAK inhibitors in non-small cell lung carcinomas with mutually inactivated p53 and PTEN tumor suppressors.
    Dragoj M; Bankovic J; Sereti E; Stojanov SJ; Dimas K; Pesic M; Stankovic T
    Invest New Drugs; 2017 Dec; 35(6):718-732. PubMed ID: 28733702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A detailed immunohistochemical analysis of the PI3K/AKT/mTOR pathway in lung cancer: correlation with PIK3CA, AKT1, K-RAS or PTEN mutational status and clinicopathological features.
    Trigka EA; Levidou G; Saetta AA; Chatziandreou I; Tomos P; Thalassinos N; Anastasiou N; Spartalis E; Kavantzas N; Patsouris E; Korkolopoulou P
    Oncol Rep; 2013 Aug; 30(2):623-36. PubMed ID: 23728071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of miR-22 reverses paclitaxel-induced chemoresistance through activation of PTEN signaling in p53-mutated colon cancer cells.
    Li J; Zhang Y; Zhao J; Kong F; Chen Y
    Mol Cell Biochem; 2011 Nov; 357(1-2):31-8. PubMed ID: 21594648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential sensitivity of human glioblastoma LN18 (PTEN-positive) and A172 (PTEN-negative) cells to Taxol for apoptosis.
    Zhang R; Banik NL; Ray SK
    Brain Res; 2008 Nov; 1239():216-25. PubMed ID: 18804099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulated Mucin 1 alleviates paclitaxel resistance in non‑small cell lung cancer cells.
    Xu H; Gao H; Li H; Li D; Yuan W; Zhang L; Cheng P; Su X; Li Z; Wang G; Zhang T
    Mol Med Rep; 2020 Oct; 22(4):2966-2972. PubMed ID: 32945387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response and determinants of sensitivity to paclitaxel in human non-small cell lung cancer tumors heterotransplanted in nude mice.
    Perez-Soler R; Kemp B; Wu QP; Mao L; Gomez J; Zeleniuch-Jacquotte A; Yee H; Lee JS; Jagirdar J; Ling YH
    Clin Cancer Res; 2000 Dec; 6(12):4932-8. PubMed ID: 11156254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 mutations do not predict response to paclitaxel in metastatic nonsmall cell lung carcinoma.
    King TC; Akerley W; Fan AC; Moore T; Mangray S; Hsiu Chen M; Safran H
    Cancer; 2000 Aug; 89(4):769-73. PubMed ID: 10951339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non‑coding RNA MEG3 inhibits cell migration and invasion of non‑small cell lung cancer cells by regulating the miR‑21‑5p/PTEN axis.
    Lv D; Bi Q; Li Y; Deng J; Wu N; Hao S; Zhao M
    Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic Anticancer Activity of Combined Use of Caffeic Acid with Paclitaxel Enhances Apoptosis of Non-Small-Cell Lung Cancer H1299 Cells in Vivo and in Vitro.
    Min J; Shen H; Xi W; Wang Q; Yin L; Zhang Y; Yu Y; Yang Q; Wang ZN
    Cell Physiol Biochem; 2018; 48(4):1433-1442. PubMed ID: 30064123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular mechanism of erlotinib resistance in epidermal growth factor receptor mutant non-small cell lung cancer cell line H1650].
    Han R; Wang X; Zhong D; Zhao J; Chen Z; Sun L; Wang J; Zhang J
    Zhongguo Fei Ai Za Zhi; 2012 Dec; 15(12):689-93. PubMed ID: 23249714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.